Skip to main content
Premium Trial:

Request an Annual Quote

Celera Completes Shotgun Sequence of Drosophila Genome, Begins Work On Human

Premium

ROCKVILLE, Md.--Celera Genomics announced last week that is has completed the random shotgun sequencing phase of its work on the Drosophila genome and will begin releasing data to the public in October.

The company said it will now dedicate its complete sequencing resources--a stable of 300 Perkin-Elmer ABI 3700 sequencing machines--to the human genome. The Drosophila sequence is the first to be generated by Celera since Craig Venter and Perkin-Elmer established the company last summer.

Anthony Kerlavage, senior director of bioinformatics for Celera, told BioInform that Celera was able to identify thousands of new genes in commercially important protein families in the organism.

Kerlavage also noted that Celera generated more than 1.8 billion base pairs of raw sequence, or 10x coverage, on what is assumed to be a 180-megabase genome since beginning its work on the Drosophila sequence just four months ago. In comparison, scientists at the Institute for Genomic Research spent more than a year on the shotgun sequence of the two-megabase Haemophilus influenzae genome, which was completed in 1995. Drosophila is the largest organism to be sequenced so far by the whole-genome shotgun method. Celera anticipates that the human genome is comprised of 3.5 gigabases.

Last month, Celera revealed that preliminary results of the Drosophila project indicated that the genome might be larger than was at first predicted, but Kerlavage said the exact size will not be known until additional phases of the project are completed.

Computational assembly of the genome using a bioinformatics tool developed by Gene Myers of Celera and data annotation will be undertaken next in collaboration with the Berkeley Drosophila Genome Project. Then, regions of the genome that are not amenable to automatic sequencing--gaps--will be closed by Berkeley in a "finishing" phase, according to Kerlavage.

Celera and the Berkeley team plan to jointly publish the final results of their research in a peer-reviewed journal early in 2000.

--Adrienne Burke

Filed under

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.